Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 135 Pages
Report ld: 3497355
Request Sample
Customized Report
Paclitaxel-Coated PTA Balloon Catheter Market Size(US$)

CAGR 2025-2031
4.9%
Market Size,2031
USD 354
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
A paclitaxel-coated PTA balloon catheter is a specialized medical device used in interventional cardiology and vascular interventions. It is designed to dilate narrowed or blocked blood vessels (arteries or veins) in a procedure known as angioplasty. The catheter is coated with paclitaxel, a drug that inhibits cell proliferation and helps prevent restenosis, which is the re-narrowing of the treated blood vessel after angioplasty.
The demand for paclitaxel-coated PTA balloon catheters has grown significantly over the years due to their potential to improve long-term outcomes in patients undergoing angioplasty. These devices are used in interventional cardiology and vascular surgery settings worldwide.
The effectiveness of paclitaxel-coated PTA balloon catheters in reducing restenosis rates and improving clinical outcomes has been demonstrated in various clinical studies and trials. The ongoing research and development in the field contribute to the expansion of the market and the improvement of catheter designs.
The global paclitaxel-coated PTA balloon catheter market has shown significant potential for growth due to its clinical benefits and increasing adoption in various healthcare facilities. Key players in the medical device industry are actively involved in the development and commercialization of these devices, contributing to market competition and innovation.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel-Coated PTA Balloon Catheter, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Paclitaxel-Coated PTA Balloon Catheter by region & country, by Type, and by Application.
The Paclitaxel-Coated PTA Balloon Catheter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel-Coated PTA Balloon Catheter.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Paclitaxel-Coated PTA Balloon Catheter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Paclitaxel-Coated PTA Balloon Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Paclitaxel-Coated PTA Balloon Catheter in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Paclitaxel-Coated PTA Balloon Catheter Product Introduction
1.2 Global Paclitaxel-Coated PTA Balloon Catheter Market Size Forecast
1.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value (2020-2031)
1.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume (2020-2031)
1.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Price (2020-2031)
1.3 Paclitaxel-Coated PTA Balloon Catheter Market Trends & Drivers
1.3.1 Paclitaxel-Coated PTA Balloon Catheter Industry Trends
1.3.2 Paclitaxel-Coated PTA Balloon Catheter Market Drivers & Opportunity
1.3.3 Paclitaxel-Coated PTA Balloon Catheter Market Challenges
1.3.4 Paclitaxel-Coated PTA Balloon Catheter Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Paclitaxel-Coated PTA Balloon Catheter Players Revenue Ranking (2024)
2.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Company (2020-2025)
2.3 Global Paclitaxel-Coated PTA Balloon Catheter Players Sales Volume Ranking (2024)
2.4 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Company Players (2020-2025)
2.5 Global Paclitaxel-Coated PTA Balloon Catheter Average Price by Company (2020-2025)
2.6 Key Manufacturers Paclitaxel-Coated PTA Balloon Catheter Manufacturing Base and Headquarters
2.7 Key Manufacturers Paclitaxel-Coated PTA Balloon Catheter Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Paclitaxel-Coated PTA Balloon Catheter
2.9 Paclitaxel-Coated PTA Balloon Catheter Market Competitive Analysis
2.9.1 Paclitaxel-Coated PTA Balloon Catheter Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Paclitaxel-Coated PTA Balloon Catheter Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel-Coated PTA Balloon Catheter as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Balloon Diameter 2-4 mm
3.1.2 Balloon Diameter 4-8 mm
3.1.3 Others
3.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type
3.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value, by Type (2020-2031)
3.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value, by Type (%) (2020-2031)
3.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Type
3.3.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume, by Type (2020-2031)
3.3.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume, by Type (%) (2020-2031)
3.4 Global Paclitaxel-Coated PTA Balloon Catheter Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application
4.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value, by Application (2020-2031)
4.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value, by Application (%) (2020-2031)
4.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Application
4.3.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume, by Application (2020-2031)
4.3.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume, by Application (%) (2020-2031)
4.4 Global Paclitaxel-Coated PTA Balloon Catheter Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region
5.1.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region (2020-2025)
5.1.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region (2026-2031)
5.1.4 Global Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region (%), (2020-2031)
5.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Region
5.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Region (2020-2025)
5.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Region (2026-2031)
5.2.4 Global Paclitaxel-Coated PTA Balloon Catheter Sales Volume by Region (%), (2020-2031)
5.3 Global Paclitaxel-Coated PTA Balloon Catheter Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
5.4.2 North America Paclitaxel-Coated PTA Balloon Catheter Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
5.5.2 Europe Paclitaxel-Coated PTA Balloon Catheter Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
5.6.2 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
5.7.2 South America Paclitaxel-Coated PTA Balloon Catheter Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
5.8.2 Middle East & Africa Paclitaxel-Coated PTA Balloon Catheter Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Paclitaxel-Coated PTA Balloon Catheter Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Paclitaxel-Coated PTA Balloon Catheter Sales Value
6.2.1 Key Countries/Regions Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.2.2 Key Countries/Regions Paclitaxel-Coated PTA Balloon Catheter Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.3.2 United States Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.4.2 Europe Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.5.2 China Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.5.3 China Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.6.2 Japan Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.7.2 South Korea Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.8.2 Southeast Asia Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Paclitaxel-Coated PTA Balloon Catheter Sales Value, 2020-2031
6.9.2 India Paclitaxel-Coated PTA Balloon Catheter Sales Value by Type (%), 2024 VS 2031
6.9.3 India Paclitaxel-Coated PTA Balloon Catheter Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Medtronic Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.2.5 Medtronic Recent Development
7.3 Cardionovum
7.3.1 Cardionovum Company Information
7.3.2 Cardionovum Introduction and Business Overview
7.3.3 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.3.5 Cardionovum Recent Development
7.4 QT Vascular
7.4.1 QT Vascular Company Information
7.4.2 QT Vascular Introduction and Business Overview
7.4.3 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.4.5 QT Vascular Recent Development
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Company Information
7.5.2 Meril Life Sciences Introduction and Business Overview
7.5.3 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.5.5 Meril Life Sciences Recent Development
7.6 Aachen Resonance Entwicklungsgesellschaft
7.6.1 Aachen Resonance Entwicklungsgesellschaft Company Information
7.6.2 Aachen Resonance Entwicklungsgesellschaft Introduction and Business Overview
7.6.3 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.6.5 Aachen Resonance Entwicklungsgesellschaft Recent Development
7.7 Biotronik
7.7.1 Biotronik Company Information
7.7.2 Biotronik Introduction and Business Overview
7.7.3 Biotronik Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Biotronik Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.7.5 Biotronik Recent Development
7.8 Hemoteq
7.8.1 Hemoteq Company Information
7.8.2 Hemoteq Introduction and Business Overview
7.8.3 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.8.5 Hemoteq Recent Development
7.9 Eucatech
7.9.1 Eucatech Company Information
7.9.2 Eucatech Introduction and Business Overview
7.9.3 Eucatech Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Eucatech Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.9.5 Eucatech Recent Development
7.10 B.Braun
7.10.1 B.Braun Company Information
7.10.2 B.Braun Introduction and Business Overview
7.10.3 B.Braun Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 B.Braun Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.10.5 B.Braun Recent Development
7.11 Biosensors International
7.11.1 Biosensors International Company Information
7.11.2 Biosensors International Introduction and Business Overview
7.11.3 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.11.5 Biosensors International Recent Development
7.12 Eurocor
7.12.1 Eurocor Company Information
7.12.2 Eurocor Introduction and Business Overview
7.12.3 Eurocor Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Eurocor Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.12.5 Eurocor Recent Development
7.13 Invamed
7.13.1 Invamed Company Information
7.13.2 Invamed Introduction and Business Overview
7.13.3 Invamed Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Invamed Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.13.5 Invamed Recent Development
7.14 IVascular
7.14.1 IVascular Company Information
7.14.2 IVascular Introduction and Business Overview
7.14.3 IVascular Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 IVascular Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.14.5 IVascular Recent Development
7.15 Lutonix
7.15.1 Lutonix Company Information
7.15.2 Lutonix Introduction and Business Overview
7.15.3 Lutonix Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Lutonix Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.15.5 Lutonix Recent Development
7.16 Zylox-Tonbridge
7.16.1 Zylox-Tonbridge Company Information
7.16.2 Zylox-Tonbridge Introduction and Business Overview
7.16.3 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Product Offerings
7.16.5 Zylox-Tonbridge Recent Development
8 Industry Chain Analysis
8.1 Paclitaxel-Coated PTA Balloon Catheter Industrial Chain
8.2 Paclitaxel-Coated PTA Balloon Catheter Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Paclitaxel-Coated PTA Balloon Catheter Sales Model
8.5.2 Sales Channel
8.5.3 Paclitaxel-Coated PTA Balloon Catheter Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 131
USD 2900.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 108
USD 4250.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market is projected to grow from US$ 255 million in 2024 to US$ 354 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-01-13
Pages: 98
USD 2900.00
(Single User License)
Published Date: 2024-02-05
Pages: 98
USD 2900.00
(Single User License)
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 150
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 131
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 108
The global Paclitaxel-Coated PTA Balloon Catheter market is projected to grow from US$ 255 million in 2024 to US$ 354 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-01-13
Pages: 98
Published: 2024-02-05
Pages: 98
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now